SmithRx’s Post

SoNE's CEO Lisa Trumble joins the MTVA team in a thought-provoking conversation with AJ Loiacono, CEO and Founder of Capital Rx, delving into the intricacies of pharmacy benefits and the challenges faced by employers in navigating the healthcare landscape. Loiacono provides insights into the complexities of drug pricing, the far-reaching effects of the Consolidated Appropriations Act (CAA), high-cost drugs, and the importance of data in optimizing valuable health plans. Hear the podcast here: https://hubs.ly/Q02br7Zm0

Exploring innovative solutions in #healthcare, a recent study has made a breakthrough in the opioid crisis. By integrating actionable guidance with notifications about #patient overdoses, physicians reduced opioid prescriptions by 13%. This strategic approach not only empowers doctors with the right information at critical moments but also signifies a major step forward in addressing #prescription drug use. Such insights are crucial for healthcare professionals committed to safe and effective #pain management. Read more at https://lnkd.in/gQ2R2VNZ USC Schaeffer Center for Health Policy & Economics | USC Mann Division of Healthcare and Biopharmaceutical Business

The main #content of the #NCCUPN  #DigitalTransformation (#DTF) #Fund  #Team (09% #arm https://lnkd.in/gthBS-P) is to #identify #collaborate with #strategic #community #partners and #catalytic #forprofit #nonprofit #organizations to support practical and #transformative #techdriven #solutions, that put #underserved #communities at the #center of #recovery (e. g. #pandemic) and #future #growth. For more #details https://lnkd.in/d2HQEY63.

Compare the expense of drug therapy to the cost-effectiveness of pharmacogenomics tests. Precision medicine ensures optimal treatment outcomes, potentially reducing long-term healthcare costs. Contact RashoRx now: www.rashorx.com #PharmacogenomicTesting #PGxTesting #Pharmacogenomics #testingservice #HealthAndWellness #RashoRx #healthcare

Using a drug off-label for one patient can actually unlock its use for many others. As Co-Founder Tracey Sikora states, drug repurposing is unique compared to novel drug development because it capitalizes on medications that are already available at pharmacies. These drugs have established safety profiles, and through off-label prescribing, patients can access these treatments without the long wait times and high costs associated with developing new drugs from scratch. This approach not only speeds up the availability of potentially life-saving treatments but also significantly reduces the financial burden on the healthcare system. At Every Cure, we are leveraging this initial use to raise awareness of these treatment options for other patients. Our goal is to ensure clinicians consider these existing drugs as viable options for their patients, expanding the reach and impact of effective treatments. #DrugRepurposing #HealthcareInnovation #PatientCare #MedicalBreakthroughs #OffLabelUse

With a couple taps on your phone you can deposit a check into your bank account or you can learn how many minutes you were (or were not!) in REM sleep last night. Why is it we still have important information about how to properly take a prescription, side effects and adverse reactions on a meticulously folded “Prescribing Information” pamphlet? Since August, the Axia Institute has brought together stakeholders in the pharmaceutical value chain to look at opportunities to make information more accessible to providers and patients when they need it. On April 24th, more than 20 stakeholders are meeting in person to develop a framework for an e-leaflet pilot program. Making prescription information easily accessible anywhere, anytime for providers and patients will lead to better health outcomes. https://lnkd.in/grR9Er9a #e-leaflet #pharma #Rx #health  

Patient centricity has different definitions, meanings, and implications throughout the industry, but is true patient centricity being achieved? Based on a survey of people working in drug development, patients and healthcare professionals, we summarised our findings in this report: https://ow.ly/6tf750Q2ase #PatientCentricity #PatientExperience #Pharma #Healthcare

➡Black patients are 25% less likely to be discharged from the hospital on a direct-acting oral anticoagulant for atrial fibrillation than white patients3  ➡Women face a 20% higher chance of developing heart failure or dying within five years of their first heart attack than men ➡ Hispanic patients are 50% more likely to die from diabetes than white patients How can pharmaceutical companies play a crucial role in advancing health equity? Read the full article, by Dr Tim Ringrose, CEO and Founder of Cognitant here. 👉 https://lnkd.in/ekH8qiNS #healthinequalities #healthequity #healthequitynow #pharmainnovation

💊🔄 Curious about biosimilars and their role in battling rising drug prices? Dive into this article for an insightful look at how these alternatives are making a positive impact. Share the knowledge and empower others to navigate healthcare costs wisely. 💙🌐 https://lnkd.in/ei_5zxiR #SBB #SeniorsBlueBook #Biosimilars #DrugPriceSolutions #HealthcareInnovation Article submitted by

The path to market for new medical technology can be challenging, and keeping up with the ever evolving pharmaceutical and biotech landscape is vital for success. Our experts are leaders in developing new solutions and understanding how changes like the new EU HTA Regulation and US Inflation Reduction Act will impact our clients. We understand the complex path to the market, and we regularly share our insights and can offer bespoke training to your teams. Visit the perspectives page on our website to read our latest insights and find out how we can illuminate the path to market for your health technology. https://buff.ly/40bbDrM #HEOR #Pharma #Biotech #HTA